Abstract
The development of non-animal methodology to evaluate the potential for a chemical to cause systemic toxicity is one of the grand challenges of modern science. The European research programme SEURAT is active in this field and will conclude its first phase, SEURAT-1, in December 2015. Drawing on the experience gained in SEURAT-1 and appreciating international advancement in both basic and regulatory science, we reflect here on how SEURAT should evolve and propose that further research and development should be directed along two complementary and interconnecting work streams. The first work stream would focus on developing new ‘paradigm’ approaches for regulatory science. The goal here is the identification of ‘critical biological targets’ relevant for toxicity and to test their suitability to be used as anchors for predicting toxicity. The second work stream would focus on integration and application of new approach methods for hazard (and risk) assessment within the current regulatory ‘paradigm’, aiming for acceptance of animal-free testing strategies by regulatory authorities (i.e. translating scientific achievements into regulation). Components for both work streams are discussed and may provide a structure for a future research programme in the field of predictive toxicology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29(3):730–741
AXLR8 (2012) Alternative testing strategies: progress report 2012 & AXLR8-3 workshop report on a ‘roadmap to next generation safety testing under horizon 2020’. Self-publishing, Berlin. http://axlr8.eu/assets/axlr8-progress-report-2012.pdf. Accessed 14 Nov 2014
Bouhifd M, Hogberg HT, Kleensang A, Maertens A, Zhao L, Hartung T (2014) Mapping the human toxome by systems toxicology. Basic Clin Pharmacol Toxicol 115(1):24–31
Clewell HJ 3rd (1995) The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances. Toxicol Lett 79(1–3):207–217
Collins FS, Gray GM, Bucher JR (2008) Toxicology. Transforming environmental health protection. Science 319(5865):906–907
Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ (2007) The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95(1):5–12
Enoch SJ, Cronin MT, Schultz TW, Madden JC (2008) Quantitative and mechanistic read across for predicting the skin sensitization potential of alkenes acting via Michael addition. Chem Res Toxicol 21(2):513–520
European Commission (2013) Communication from the Commission to the European Parliament and the Council on the animal testing and marketing ban and on the state of play in relation to alternative methods in the field of cosmetics. Brussels. http://ec.europa.eu/consumers/archive/sectors/cosmetics/files/pdf/animal_testing/com_at_2013_en.pdf. Accessed 14 Nov 2014
Gocht T, Schwarz M (2014) Towards the replacement of in vivo repeated dose systemic toxicity. Self-publishing, Paris. http:/www.seurat-1.eu/pages/library/seurat-1-annual-report.php. Accessed 14 Nov 2014
Gocht T, Berggren E, Ahr HJ, Cotgreave I, Cronin MT, Daston G, Hardy B, Heinzle E, Hescheler J, Knight DJ, Mahony C, Peschanski M, Schwarz M, Thomas RS, Verfaillie C, White A, Whelan M (2014) The SEURAT-1 approach towards animal free human safety assessment. ALTEX. doi:10.14573/altex.1408041
Judson RS, Kavlock RJ, Setzer RW, Hubal EA, Martin MT, Knudsen TB, Houck KA, Thomas RS, Wetmore BA, Dix DJ (2011) Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment. Chem Res Toxicol 24(4):451–462
Kavlock R, Chandler K, Houck K, Hunter S, Judson R, Kleinstreuer N, Knudsen T, Martin M, Padilla S, Reif D, Richard A, Rotroff D, Sipes N, Dix D (2012) Update on EPA’s ToxCast program: providing high throughput decision support tools for chemical risk management. Chem Res Toxicol 25(7):1287–1302
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929–1935
NRC: National Research Council (2007) Toxicity testing in the 21st century: a vision and a strategy. National Academies Press, Washington DC
OECD: Organisation for Economic Co-operation and Development (2013) Guidance document on developing and assessing adverse outcome pathways. OECD environment, health and safety publications—series on testing and assessment, No.184. Paris, France
Pastoor TP, Bachmann AN, Bell DR, Cohen SM, Dellarco M, Dewhurst IC, Doe JE, Doerrer NG, Embry MR, Hines RN, Moretto A, Phillips RD, Rowlands JC, Tanir JY, Wolf DC, Boobis AR (2014) A 21st century roadmap for human health risk assessment. Crit Rev Toxicol 44(S3):1–5
Patlewicz G, Ball N, Becker RA, Booth ED, Cronin MT, Kroese D, Steup D, van Ravenzwaay B, Hartung T (2014) Read-across approaches: misconceptions, promises and challenges ahead. ALTEX 31(4):387–396
Rotroff DM, Wetmore BA, Dix DJ, Ferguson SS, Clewell HJ, Houck KA, Lecluyse EL, Andersen ME, Judson RS, Smith CM, Sochaski MA, Kavlock RJ, Boellmann F, Martin MT, Reif DM, Wambaugh JF, Thomas RS (2010) Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicol Sci 117(2):348–358
Thomas RS, Philbert MA, Auerbach SS, Wetmore BA, Devito MJ, Cote I, Rowlands JC, Whelan MP, Hays SM, Andersen ME, Meek ME, Reiter LW, Lambert JC, Clewell HJ 3rd, Stephens ML, Zhao QJ, Wesselkamper SC, Flowers L, Carney EW, Pastoor TP, Petersen DD, Yauk CL, Nong A (2013) Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci 136(1):4–18
Tice RR, Austin CP, Kavlock RJ, Bucher JR (2013) Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect 121(7):756–765
WHO: World Health Organization (2014) Guidance document on evaluation and expressing uncertainty in hazard characterization. IPSC harmonisation project document, no. 11, Geneva, Switzerland
Wu S, Blackburn K, Amburgey J, Jaworska J, Federle T (2010) A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. Regul Toxicol Pharmacol 56(1):67–81
Acknowledgments
This work has received funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement no 267044 (project acronym ‘COACH’) and has received financing from Cosmetics Europe.
Author information
Authors and Affiliations
Corresponding author
Additional information
The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the US Environmental Protection Agency, the European Commission and the European Chemicals Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.
Rights and permissions
About this article
Cite this article
Daston, G., Knight, D.J., Schwarz, M. et al. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing—Recommendations for future research in the field of predictive toxicology. Arch Toxicol 89, 15–23 (2015). https://doi.org/10.1007/s00204-014-1421-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-014-1421-5